Sildenafil Citrate USP For Compounding (API)

Sildenafil Citrate USP for Compounding (API) is an active pharmaceutical ingredient used in the preparation of customized medications primarily for the treatment of erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). By inhibiting the enzyme phosphodiesterase type 5 (PDE5), sildenafil enhances blood flow to the penis, facilitating an erection in response to sexual stimulation, and also relaxes blood vessels in the lungs to improve exercise capacity in individuals with PAH. Compounded formulations allow for tailored dosages and dosage forms to meet specific patient needs and preferences. 

Sildenafil Citrate USP is a medication that is commonly used for compounding purposes. It is a potent inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), which is an enzyme that helps to regulate blood flow in the body. When used in compounding, it is typically combined with other ingredients to create customized medications for the treatment of erectile dysfunction, pulmonary arterial hypertension, and other circulatory disorders. Sildenafil Citrate USP is also used in compounding to treat female sexual arousal disorder and other sexual dysfunction disorders. Additionally, it may be used to treat hypertension (high blood pressure) in patients who are not responding to traditional treatments. 

Sildenafil Citrate USP is an active pharmaceutical ingredient (API) used in medications to treat erectile dysfunction and pulmonary arterial hypertension. It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which work by relaxing the smooth muscles and increasing blood flow to the penis, promoting an erection. Sildenafil Citrate USP is the standardized form of sildenafil, the generic name for the branded medication Viagra. It is a prescription-only medication and is available as tablets of various strengths.

Cas Number: 171599-83-0
Property: Hygroscopic